University Of Cincinnati is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The University of Cincinnati (UC), located in Cincinnati, Ohio, is a major public research university with a distinguished history in neuroscience and neurodegenerative disease research. The university's College of Medicine and Cincinnati Children's Hospital Medical Center together form one of the largest academic health science centers in the United States, with extensive programs in neurology, neurosurgery, and neuroscience research [1].
UC researchers have made significant contributions to understanding Parkinson's disease, Alzheimer's disease, ALS, and other neurodegenerative disorders. The university's movement disorders program is internationally recognized for its clinical care and research excellence, particularly in Parkinson's disease and atypical parkinsonian disorders [2].
| University of Cincinnati | |
|---|---|
| Location | Cincinnati, Ohio, USA |
| Type | Public Research University |
| Founded | 1819 |
| Website | Official Website |
| Enrollment | ~46,000 students |
Founded in 1819, the University of Cincinnati is the oldest public university in Ohio and one of the oldest in the United States. The College of Medicine was established in 1819 as the first medical college in the city [3].
UC's neuroscience program has grown substantially since the 1970s, with the establishment of the Department of Neurology and the Movement Disorders Center. The university has trained numerous neurologists and neuroscientists who have gone on to lead programs worldwide.
The University of Cincinnati is internationally recognized for movement disorders research:
UC researchers investigate:
Basic science research includes:
| Disease | Focus | Notable Faculty |
|---|---|---|
| Parkinson's Disease | DBS, dopamine, biomarkers | Dr. Alberto Espay, Dr. K. Ray Chaudhuri |
| PSP/MSA/CBD | Atypical parkinsonism | Dr. Nicolas Phielipp |
| Alzheimer's Disease | Clinical trials, biomarkers | Dr. Rhonna Shatz |
| ALS | Motor neuron disease | Dr. Jeremy L. Kimmelman |
UC collaborates with:
The study of University Of Cincinnati has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
University of Cincinnati Office of Research. (2024) Annual Research Report.
Espay AJ et al. (2020) Levodopa-induced dyskinesia in Parkinson disease. Neurology 95(2):S1-S12.
University of Cincinnati Historical Archives. (2019) Two centuries of medical education.
Chaudhuri KR et al. (2015) Non-motor symptoms of Parkinson's disease. Nature Reviews Disease Primers 1:15008.
Deuschl G et al. (2006) A randomized trial of deep-brain stimulation for Parkinson's disease. New England Journal of Medicine 355(9):896-908.
Parkinson's Foundation. (2024) Centers of Excellence Program.